J.P. Morgan Thinks Clovis Oncology’s Stock is Going to Recover

In a report issued on October 19, Cory Kasimov from J.P. Morgan maintained a Buy rating on Clovis Oncology (NASDAQ: CLVS). The company’s shares closed on Friday at $26.36, close to its More »

Adobe (ADBE) Receives a Buy from Rosenblatt Securities

In a report issued on October 18, Marshall Senk from Rosenblatt Securities maintained a Buy rating on Adobe (NASDAQ: ADBE), with a price target of $280. The company’s shares closed on Friday More »